NATCO Pharma LimitedNSE: NATCOPHARM

Press Release Feb 10 2025

· Issued by NATCO Pharma Limited

Filed with NSE ·

Natco Pharma Limited has informed the Exchange regarding a press release dated February 10, 2025, titled "NATCO announces final approval of its ANDA for Bosentan tablets".

View Attachment

6ix hasn’t read this filing yet.

NATCO Pharma Limited on 6ix

In the deck

Earlier from NATCO Pharma

Later from NATCO Pharma

All NATCO Pharma news releases